Last edition
News about "Neovascular Age-related Macular Degeneration "
CHMP Recommends EU Approval of Roche's Susvimo
The Committee for Medicinal Products for Human Use (CHMP) has recommended EU approval of Roche's Susvimo, the first continuous delivery treatment offering an alternative to regular eye injections for wet Age-related Macular Degeneration (AMD).
Neovascular Age-related Macular Degeneration | 25/07/2026 | By News Bureau
Lupin Completes Phase 3 Trials for Lucentis Biosimilar
Lupin has successfully completed a global Phase 3 clinical study of LUBT010, its biosimilar candidate to Lucentis.
Neovascular Age-related Macular Degeneration | 06/08/2024 | By Aishwarya | 737
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy